Glucocorticoid in excess produces bone loss in vivo. Consistent with this, it reduces the stimulatory effect of transforming growth factor  (TGF-) on collagen synthesis in osteoblast-enriched cultures in vitro, where it also suppresses TGF- binding to its type I receptors. Analogous studies with
Effects of bone morphogenetic protein-2 on bone cells in primary culture: Immunohistochemical and electronmicroscopical studies
✍ Scribed by D. Bingmann; M. Wiemann; K. Schirrmacher; N. Prochnow; I. Schmitz; K. M. Müller; W. Sebald
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 445 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0933-5137
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recombinant human bone morphogenetic protein-2 (rhBMP-2) is known to induce orthotopic and ectopic bone formation in vivo. Several in vitro studies using rat or mouse clonal cell lines have shown that rhBMP-2 may be involved in the differentiation of osteoblasts from osteoblast precursor cells or st
Bone morphogenetic proteins (BMPs) are factors that promote osteoblastic cell differentiation and osteogenesis. It is unknown whether BMPs may act on human osteoblastic cells by increasing immature cell growth and/or differentiation. We investigated the short- and long-term effects of recombinant hu
Bone morphogenetic proteins (BMPs) are a family of growth differentiation factors which induce bone formation from mesenchymal cells. These proteins are members of the transforming growth factor-beta super-family. The expression of BMPs in the nervous system as well as in other tissues has been repo
Bone morphogenetic proteins (BMPs) induce osteoblastic responses in cultures of pluripotent mesenchymal cells. The effects of chronic treatment of these cells with BMPs and of withdrawal following exposure, however, have not been fully elucidated. Thus, the aim of this study was to obtain informatio